Cash flow Max Healthcare Institute Limited

Equities

543220

INE027H01010

Healthcare Facilities & Services

Market Closed - Bombay S.E. Other stock markets 11:00:51 15/05/2026 BST			5-day change	1st Jan Change
1,050.00 ^INR	+0.02%		+3.44%	+0.49%

04-08	Max Healthcare Institute to Acquire Majority Stake in Kalinga Hospital	MT
04-08	Max Healthcare Institute Ltd approves acquisition of 58.39% controlling stake in Kalinga Hospital	RE

0cf41e1a.p_IWz3jIYcJ7yvbddS0U5evFBO24n_OcoGzFFfT0RdU.y6N79kukDa0Th4OpNE91qIe2YN_xrbvR5yqQYJ6MBrHxq3v7LI0E8zP5lQ

Published financial data: MAX HEALTHCARE INSTITUTE LIMITED

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2021	2022	2023	2024	2025
Revenues	25.05B	39.31B	45.63B	54.06B	70.28B
Other Revenues, Total	33M	-	-	-	-
Total Revenues	25.08B	39.31B	45.63B	54.06B	70.28B
Cost of Goods Sold, Total	12.32B	17.48B	18.01B	20.53B	26.51B
Gross Profit	12.76B	21.83B	27.61B	33.53B	43.77B
Selling General & Admin Expenses, Total	5.66B	8.73B	10.69B	11.17B	14.75B
Provision for Bad Debts	323M	-	-	-	-
Depreciation & Amortization - (IS)	1.74B	2.21B	2.32B	2.45B	3.59B
Other Operating Expenses	2.6B	3.36B	4.36B	7.16B	10.16B
Other Operating Expenses, Total	10.32B	14.31B	17.37B	20.78B	28.5B
Operating Income	2.43B	7.53B	10.24B	12.75B	15.28B
Interest Expense, Total	-1.71B	-900M	-713M	-446M	-1.49B
Interest And Investment Income	767M	751M	1.12B	1.56B	1.17B
Net Interest Expenses	-943M	-149M	411M	1.12B	-315M
Income (Loss) On Equity Invest.	-230M	-	-	-	-
Currency Exchange Gains (Loss)	179M	-3.4M	-2.4M	3M	-7M
Other Non Operating Income (Expenses)	67.4M	258M	86.7M	41.6M	204M
EBT, Excl. Unusual Items	1.5B	7.63B	10.74B	13.91B	15.16B
Restructuring Charges	-	-90.3M	-	-	-
Merger & Related Restructuring Charges	-378M	-	-	-	-
Gain (Loss) On Sale Of Investments	-	-	-	-	-
Gain (Loss) On Sale Of Assets	-2.4M	-30.6M	13.3M	4.5M	1.1M
Asset Writedown	-81.4M	-600K	-	-	-
Other Unusual Items	-1.96B	-124M	-111M	-265M	-1.1B
EBT, Incl. Unusual Items	-917M	7.39B	10.64B	13.65B	14.06B
Income Tax Expense	458M	1.34B	-398M	3.08B	3.3B
Earnings From Continuing Operations	-1.38B	6.05B	11.04B	10.58B	10.76B
Earnings Of Discontinued Operations	-	-	-	-	-
Net Income to Company	-1.38B	6.05B	11.04B	10.58B	10.76B
Minority Interest	-	-	-	-	-
Net Income - (IS)	-1.38B	6.05B	11.04B	10.58B	10.76B
Preferred Dividend and Other Adjustments	-	-	-	-	-
Net Income to Common Incl Extra Items	-1.38B	6.05B	11.04B	10.58B	10.76B
Net Income to Common Excl. Extra Items	-1.38B	6.05B	11.04B	10.58B	10.76B
Per Share Items
Net EPS - Basic	-1.59	6.25	11.38	10.89	11.07
Basic EPS - Continuing Operations	-1.59	6.25	11.38	10.89	11.07
Basic Weighted Average Shares Outstanding	863M	967M	970M	972M	972M
Net EPS - Diluted	-1.59	6.24	11.36	10.84	11.01
Diluted EPS - Continuing Operations	-1.59	6.24	11.36	10.84	11.01
Diluted Weighted Average Shares Outstanding	863M	969M	972M	975M	977M
Normalized Basic EPS	1.09	4.93	6.92	8.95	9.75
Normalized Diluted EPS	1.09	4.92	6.9	8.92	9.69
Dividend Per Share	-	-	1	1.5	1.5
Payout Ratio	-	-	-	9.17	13.53
Supplemental Items
EBITDA	3.9B	9.41B	12.23B	14.82B	18.31B
EBITA	2.8B	7.97B	10.69B	13.18B	15.7B
EBIT	2.43B	7.53B	10.24B	12.75B	15.28B
EBITDAR	4.06B	9.6B	12.48B	-	-
Total Revenues (As Reported)	26.19B	40.59B	47.02B	55.84B	71.84B
Effective Tax Rate - (Ratio)	-50	18.11	-3.74	22.54	23.5
Current Domestic Taxes	-	1.16B	2.05B	2.71B	-
Total Current Taxes	16.2M	1.16B	2.05B	2.71B	3.36B
Deferred Domestic Taxes	-	180M	-2.45B	364M	-
Total Deferred Taxes	434M	180M	-2.45B	364M	-56.2M
Normalized Net Income	940M	4.77B	6.71B	8.7B	9.47B
Interest Capitalized	-	-	-	-	-
Interest on Long-Term Debt	170M	192M	168M	152M	445M
Non-Cash Pension Expense	36.6M	37.7M	41.3M	48.5M	57.8M
Supplemental Operating Expense Items
Advertising Expense	168M	446M	576M	-	-
Selling and Marketing Expenses	168M	446M	576M	-	-
General and Administrative Expenses	5.33B	8.09B	9.86B	11.17B	14.75B
Research And Development Expense From Footnotes	57.3M	3.28M	3.6M	5.11M	7.56M
Net Rental Expense, Total	160M	188M	250M	-	-
Imputed Operating Lease Interest Expense	222M	135M	178M	-	-
Imputed Operating Lease Depreciation	-61.56M	53.76M	72.02M	-	-
Maintenance & Repair Expenses, Total	492M	652M	701M	-	-
Stock-Based Comp., COGS (Total)	326M	468M	344M	496M	546M
Total Stock-Based Compensation	326M	468M	344M	496M	546M

Fiscal Period: March	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	6.27B	3.09B	428M	9.8B	6.62B
Short Term Investments	2M	1.72B	12.35B	-	-
Total Cash And Short Term Investments	6.27B	4.81B	12.78B	9.8B	6.62B
Accounts Receivable, Total	3.88B	4.1B	3.66B	4.97B	7.36B
Other Receivables	3M	4.6M	3.6M	73.8M	96.4M
Notes Receivable	54.3M	25.8M	-	-	104M
Total Receivables	3.94B	4.13B	3.67B	5.04B	7.56B
Inventory	538M	614M	762M	798M	1.06B
Prepaid Expenses	111M	150M	106M	131M	285M
Restricted Cash	-	-	-	-	-
Other Current Assets, Total	392M	300M	2.12B	1.29B	406M
Total Current Assets	11.24B	10B	19.43B	17.06B	15.93B
Gross Property Plant And Equipment	22.55B	26.65B	29.61B	46.39B	79.19B
Accumulated Depreciation	-4.8B	-6.07B	-7.36B	-9.48B	-15.56B
Net Property Plant And Equipment	17.75B	20.58B	22.26B	36.91B	63.62B
Long-term Investments	10.4M	20.2M	5.1M	21.2M	28.9M
Goodwill	24.55B	24.55B	24.55B	29.52B	34.8B
Other Intangibles, Total	23.34B	26.56B	26.11B	26.3B	25.55B
Accounts Receivable Long-Term	1.19B	1.08B	1.03B	966M	888M
Loans Receivable Long-Term	3.57B	1.73B	1.38B	1.38B	3.83B
Deferred Tax Assets Long-Term	9.8M	-	-	-	280M
Deferred Charges Long-Term	986M	954M	924M	892M	862M
Other Long-Term Assets, Total	2.8B	6.41B	5.34B	6.94B	6.35B
Total Assets	85.44B	91.89B	101B	120B	152B
Liabilities
Accounts Payable, Total	4.36B	4.52B	5.43B	6.77B	8.08B
Accrued Expenses, Total	929M	1.02B	1.08B	1.34B	1.9B
Short-term Borrowings	542M	745M	456M	613M	636M
Current Portion of Long-Term Debt	233M	227M	227M	275M	1.55B
Current Portion of Leases	111M	166M	163M	217M	239M
Current Income Taxes Payable	500K	-	26.8M	1M	1M
Unearned Revenue Current, Total	191M	220M	338M	494M	812M
Other Current Liabilities	1.41B	674M	2.74B	2.77B	4.92B
Total Current Liabilities	7.77B	7.57B	10.46B	12.49B	18.14B
Long-Term Debt	8.43B	6.29B	4.97B	10.61B	22.7B
Long-Term Leases	1.7B	1.7B	1.08B	1.28B	4.98B
Unearned Revenue Non Current	114M	108M	117M	169M	322M
Pension & Other Post Retirement Benefits	573M	565M	568M	712M	931M
Deferred Tax Liability Non Current	5.82B	6.81B	4.37B	5.15B	6.48B
Other Non Current Liabilities	4.65B	6.01B	5.37B	5.52B	4.79B
Total Liabilities	29.06B	29.07B	26.92B	35.92B	58.34B
Common Stock, Total	9.66B	9.7B	9.71B	9.72B	9.72B
Additional Paid In Capital	51.05B	51.43B	51.58B	51.82B	51.84B
Retained Earnings	-4.59B	1.48B	12.34B	21.88B	31.11B
Comprehensive Income and Other	265M	221M	466M	660M	1.14B
Total Common Equity	56.39B	62.82B	74.1B	84.08B	93.81B
Total Equity	56.39B	62.82B	74.1B	84.08B	93.81B
Total Liabilities And Equity	85.44B	91.89B	101B	120B	152B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	966M	970M	971M	972M	972M
ECS Total Common Shares Outstanding	966M	970M	971M	972M	972M
Book Value / Share	58.37	64.79	76.31	86.51	96.5
Tangible Book Value	8.5B	11.72B	23.44B	28.26B	33.46B
Tangible Book Value Per Share	8.8	12.09	24.14	29.07	34.41
Total Debt	11.01B	9.13B	6.89B	12.99B	30.1B
Net Debt	4.75B	4.32B	-5.89B	3.19B	23.49B
Debt Equivalent of Unfunded Proj. Benefit Obligation	642M	634M	657M	778M	1.02B
Debt Equivalent Oper. Leases	1.28B	1.51B	2B	-	-
Account Code - Inventory Valuation	5	5	5	5	5
Inventories - Finished Goods, Total	-	-	-	798M	1.06B
Land - (BS)	3.45B	5.39B	5.4B	7.49B	13.44B
Buildings, Total	4.93B	5.08B	5.43B	8.35B	13.33B
Machinery, Total	11.11B	12.12B	13.76B	17.98B	27.04B
Full Time Employees	15K	15K	15K	19.5K	15.11K
Assets under Capital Lease - Gross	-	-	-	-	-
Assets under Capital Lease - Accumulated Depreciation	-	-	-	-	-
Accumulated Allowance for Doubtful Accounts (Supple)	624M	430M	269M	362M	530M

Fiscal Period: March	2021	2022	2023	2024	2025
Net Income	-1.38B	6.05B	11.04B	10.58B	10.76B
Depreciation & Amortization - CF	1.3B	1.69B	1.8B	1.95B	3.09B
Amortization of Goodwill and Intangible Assets - (CF)	373M	446M	453M	426M	430M
Depreciation & Amortization, Total	1.67B	2.14B	2.25B	2.38B	3.52B
Amortization of Deferred Charges, Total - (CF)	71.2M	73M	69.5M	70.6M	75M
(Gain) Loss From Sale Of Asset	2.4M	30.6M	-13.3M	-4.5M	-1.1M
(Gain) Loss on Sale of Investments - (CF)	1.96B	-	-	-	-
Asset Writedown & Restructuring Costs	81.4M	600K	-	-	-
Stock-Based Compensation (CF)	265M	339M	344M	496M	546M
Provision and Write-off of Bad Debts	356M	92.4M	74.1M	110M	257M
Net Cash From Discontinued Operations	-	-	-	-	-
Other Operating Activities, Total	1.91B	79.9M	-2.48B	-819M	682M
Change In Accounts Receivable	561M	29.1M	647M	-1.09B	-2.09B
Change In Inventories	172M	-75.6M	-149M	59M	-192M
Change In Accounts Payable	-4.78B	-462M	987M	-401M	815M
Change in Other Net Operating Assets	283M	-811M	-680M	-162M	224M
Cash from Operations	1.18B	7.48B	12.09B	11.22B	14.59B
Capital Expenditure	-1.18B	-5.61B	-3.36B	-7.86B	-9.66B
Sale of Property, Plant, and Equipment	16.2M	51.7M	39.2M	63.4M	64.1M
Cash Acquisitions	-	-1.07B	-4.8M	-6.3B	-6.25B
Investment in Marketable and Equity Securities, Total	-	-1.71B	-10.76B	-12.6M	-7.7M
Net (Increase) Decrease in Loans Originated / Sold - Investing	-223M	-115M	350M	-	-2.45B
Other Investing Activities, Total	661M	742M	1.86B	1.25B	1.98B
Cash from Investing	-730M	-7.72B	-11.87B	-12.85B	-16.32B
Short Term Debt Issued, Total	-	203M	-	142M	23M
Long-Term Debt Issued, Total	7.37B	366M	70.7M	6.28B	13.47B
Total Debt Issued	7.37B	568M	70.7M	6.42B	13.49B
Short Term Debt Repaid, Total	-6.96B	-	-290M	-	-
Long-Term Debt Repaid, Total	-8.58B	-2.64B	-1.97B	-6.22B	-12.27B
Total Debt Repaid	-15.54B	-2.64B	-2.26B	-6.22B	-12.27B
Issuance of Common Stock	11.79B	36.6M	13.6M	9.9M	2.3M
Common Dividends Paid	-	-	-	-970M	-1.46B
Common & Preferred Stock Dividends Paid	-	-	-	-970M	-1.46B
Other Financing Activities, Total	-1.71B	-910M	-713M	-1.87B	-1.41B
Cash from Financing	1.91B	-2.94B	-2.89B	-2.64B	-1.64B
Foreign Exchange Rate Adjustments	-	-	-	-18.2M	1.2M
Miscellaneous Cash Flow Adjustments	2.79B	-	-	347M	175M
Net Change in Cash	5.16B	-3.17B	-2.66B	-3.94B	-3.19B
Supplemental Items
Cash Interest Paid	1.71B	910M	713M	1.87B	1.41B
Cash Income Tax Paid (Refund)	-580M	1.09B	1.61B	2.69B	3.21B
Levered Free Cash Flow	6.9B	544M	6.98B	2.97B	5.38B
Unlevered Free Cash Flow	7.97B	1.11B	7.43B	3.25B	6.31B
Change In Net Working Capital	-5.57B	665M	-1.72B	-196M	-2.28B
Net Debt Issued / Repaid	-8.17B	-2.07B	-2.19B	198M	1.22B

Fiscal Period: March	2021	2022	2023	2024	2025
Profitability
Return on Assets	2.43	5.31	6.64	7.21	7.02
Return on Total Capital	2.99	6.75	8.37	8.95	8.64
Return On Equity %	-3.36	10.15	16.12	13.37	12.1
Return on Common Equity	-3.36	10.15	16.12	13.37	12.1
Margin Analysis
Gross Profit Margin %	50.86	55.54	60.52	62.03	62.28
SG&A Margin	22.55	22.2	23.43	20.66	20.98
EBITDA Margin %	15.53	23.95	26.8	27.41	26.05
EBITA Margin %	11.18	20.28	23.44	24.38	22.34
EBIT Margin %	9.69	19.15	22.44	23.59	21.73
Income From Continuing Operations Margin %	-5.48	15.39	24.19	19.56	15.31
Net Income Margin %	-5.48	15.39	24.19	19.56	15.31
Net Avail. For Common Margin %	-5.48	15.39	24.19	19.56	15.31
Normalized Net Income Margin	3.75	12.14	14.71	16.09	13.48
Levered Free Cash Flow Margin	27.51	1.38	15.3	5.5	7.66
Unlevered Free Cash Flow Margin	31.77	2.82	16.28	6.02	8.98
Asset Turnover
Asset Turnover	0.4	0.44	0.47	0.49	0.52
Fixed Assets Turnover	2.4	2.05	2.13	1.83	1.4
Receivables Turnover (Average Receivables)	10.1	9.86	11.76	12.53	11.41
Inventory Turnover (Average Inventory)	30.58	30.36	26.19	26.31	28.5
Short Term Liquidity
Current Ratio	1.45	1.32	1.86	1.37	0.88
Quick Ratio	1.31	1.18	1.57	1.19	0.78
Operating Cash Flow to Current Liabilities	0.15	0.99	1.16	0.9	0.8
Days Sales Outstanding (Average Receivables)	36.13	37.03	31.05	29.21	32
Days Outstanding Inventory (Average Inventory)	11.94	12.02	13.94	13.91	12.81
Average Days Payable Outstanding	89.16	92.29	99.23	108.64	98.22
Cash Conversion Cycle (Average Days)	-41.1	-43.23	-54.24	-65.52	-53.41
Long Term Solvency
Total Debt/Equity	19.53	14.54	9.3	15.45	32.09
Total Debt / Total Capital	16.34	12.69	8.51	13.38	24.29
LT Debt/Equity	17.96	12.73	8.16	14.13	29.5
Long-Term Debt / Total Capital	15.03	11.11	7.46	12.24	22.34
Total Liabilities / Total Assets	34.01	31.63	26.65	29.93	38.34
EBIT / Interest Expense	1.42	8.36	14.36	28.62	10.27
EBITDA / Interest Expense	2.4	10.74	17.52	33.96	12.64
(EBITDA - Capex) / Interest Expense	1.71	4.5	12.81	16.32	6.14
Total Debt / EBITDA	2.69	0.94	0.55	0.86	1.6
Net Debt / EBITDA	1.16	0.45	-0.47	0.21	1.25
Total Debt / (EBITDA - Capex)	3.78	2.25	0.75	1.79	3.29
Net Debt / (EBITDA - Capex)	1.63	1.07	-0.64	0.44	2.57
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	136.82	56.76	15.9	18.49	30.01
Gross Profit, 1 Yr. Growth %	116.15	71.18	26.16	18.43	30.55
EBITDA, 1 Yr. Growth %	345.76	141.67	29.16	21.21	23.57
EBITA, 1 Yr. Growth %	421.82	184.48	33.24	23.25	19.17
EBIT, 1 Yr. Growth %	404.04	209.76	35.1	24.54	19.78
Earnings From Cont. Operations, 1 Yr. Growth %	-333.18	-539.88	82.38	-4.16	1.72
Net Income, 1 Yr. Growth %	-333.18	-539.88	82.38	-4.16	1.72
Normalized Net Income, 1 Yr. Growth %	184.22	407.77	40.62	29.61	8.94
Diluted EPS Before Extra, 1 Yr. Growth %	-257.79	-491.59	82.05	-4.58	1.57
Accounts Receivable, 1 Yr. Growth %	258.97	5.71	-10.65	35.59	48.13
Inventory, 1 Yr. Growth %	100.75	14.05	24.23	4.74	33.03
Net Property, Plant and Equip., 1 Yr. Growth %	457.59	15.97	8.13	65.84	72.37
Total Assets, 1 Yr. Growth %	115.03	7.55	9.93	18.79	26.79
Tangible Book Value, 1 Yr. Growth %	-57.34	37.85	99.99	20.54	18.41
Common Equity, 1 Yr. Growth %	120.85	11.42	17.94	13.48	11.57
Cash From Operations, 1 Yr. Growth %	52.89	535.07	63.29	-12.64	30.1
Capital Expenditures, 1 Yr. Growth %	31.45	374	-39.35	134.19	22.85
Levered Free Cash Flow, 1 Yr. Growth %	-167.85	-92.11	964.68	-62.57	81.03
Unlevered Free Cash Flow, 1 Yr. Growth %	-182.32	-86.11	509.62	-61.24	94.11
Dividend Per Share, 1 Yr. Growth %	-	-	-	50	0
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	21.68	92.67	34.88	17.19	24.11
Gross Profit, 2 Yr. CAGR %	22.43	92.35	47.13	23.78	24.34
EBITDA, 2 Yr. CAGR %	59.94	228.22	77.16	25.12	22.39
EBITA, 2 Yr. CAGR %	99.9	285.29	95.31	28.15	21.19
EBIT, 2 Yr. CAGR %	106.66	295.14	105.26	29.71	22.14
Earnings From Cont. Operations, 2 Yr. CAGR %	2.59K	220.26	183.24	32.21	-1.26
Net Income, 2 Yr. CAGR %	576	220.26	183.24	32.21	-1.26
Normalized Net Income, 2 Yr. CAGR %	466.31	279.89	167.21	35	18.83
Diluted EPS Before Extra, 2 Yr. CAGR %	415.35	148.58	167	31.8	-1.55
Accounts Receivable, 2 Yr. CAGR %	1.8	94.8	-2.81	10.07	41.72
Inventory, 2 Yr. CAGR %	43.82	51.31	19.03	14.07	18.04
Net Property, Plant and Equip., 2 Yr. CAGR %	31.64	154.29	11.98	33.91	69.08
Total Assets, 2 Yr. CAGR %	59.33	52.07	8.73	14.28	22.72
Tangible Book Value, 2 Yr. CAGR %	70.63	-23.31	66.04	55.26	19.47
Common Equity, 2 Yr. CAGR %	141.95	56.87	14.63	15.69	12.52
Cash From Operations, 2 Yr. CAGR %	15.11	211.6	220.3	23.08	6.6
Capital Expenditures, 2 Yr. CAGR %	1.16	149.61	68.35	19.18	69.62
Levered Free Cash Flow, 2 Yr. CAGR %	4.91	-76.87	0.58	112.98	-17.68
Unlevered Free Cash Flow, 2 Yr. CAGR %	7.7	-66.19	-3.46	63.4	-13.26
Dividend Per Share, 2 Yr. CAGR %	-	-	-	-	22.47
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	13.17	32.4	62.72	29.18	21.32
Gross Profit, 3 Yr. CAGR %	15.79	36.9	67.26	38.01	26
EBITDA, 3 Yr. CAGR %	49.77	83.53	140.96	56.11	24.6
EBITA, 3 Yr. CAGR %	88.77	124.85	171.01	67.52	25.08
EBIT, 3 Yr. CAGR %	124.29	136.51	176.92	73.77	26.31
Earnings From Cont. Operations, 3 Yr. CAGR %	68.54	1.37K	165.46	97.38	21.15
Net Income, 3 Yr. CAGR %	87.76	485.79	165.46	97.38	21.15
Normalized Net Income, 3 Yr. CAGR %	73.82	446.09	172.76	109.95	25.69
Diluted EPS Before Extra, 3 Yr. CAGR %	41.59	370.27	124.06	89.48	20.84
Accounts Receivable, 3 Yr. CAGR %	13.02	3.08	50.23	8.6	21.52
Inventory, 3 Yr. CAGR %	23.92	33.12	41.69	14.06	20.07
Net Property, Plant and Equip., 3 Yr. CAGR %	21.24	26.2	91.22	27.64	45.67
Total Assets, 3 Yr. CAGR %	37.02	39.77	36.48	11.99	18.3
Tangible Book Value, 3 Yr. CAGR %	53.4	58.92	5.56	49.23	41.85
Common Equity, 3 Yr. CAGR %	76.02	86.84	42.64	14.25	14.3
Cash From Operations, 3 Yr. CAGR %	12.75	103.4	150.32	111.93	25.37
Capital Expenditures, 3 Yr. CAGR %	21.8	69.27	55.02	87.93	20.39
Levered Free Cash Flow, 3 Yr. CAGR %	166.67	-55.72	-11.79	-24.46	101.75
Unlevered Free Cash Flow, 3 Yr. CAGR %	237.59	-45.59	-8.46	-25.82	73.06
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	11.82	19.57	21.4	26.12	46.01
Gross Profit, 5 Yr. CAGR %	12.74	22.33	27.43	31.55	49.3
EBITDA, 5 Yr. CAGR %	31.8	46.17	60.17	57.63	83.76
EBITA, 5 Yr. CAGR %	72.66	64.75	91.36	79.79	96.42
EBIT, 5 Yr. CAGR %	80.18	75.21	116.48	86.25	99.6
Earnings From Cont. Operations, 5 Yr. CAGR %	43.49	236.61	107.44	461.2	78.73
Net Income, 5 Yr. CAGR %	43.49	107.34	121.32	222.96	78.73
Normalized Net Income, 5 Yr. CAGR %	47.52	129.85	106.44	212.24	95.63
Diluted EPS Before Extra, 5 Yr. CAGR %	34.65	190.81	82.48	182.73	61.25
Accounts Receivable, 5 Yr. CAGR %	11.97	10.79	6.4	5.82	46.77
Inventory, 5 Yr. CAGR %	18.3	21.56	21.94	25.15	31.71
Net Property, Plant and Equip., 5 Yr. CAGR %	12.63	15.38	17.45	29.23	82.03
Total Assets, 5 Yr. CAGR %	22.92	23.8	24.92	28.95	30.8
Tangible Book Value, 5 Yr. CAGR %	36.85	50.4	58.33	57.45	10.92
Common Equity, 5 Yr. CAGR %	37.96	41.21	48.27	54.24	29.73
Cash From Operations, 5 Yr. CAGR %	-30.42	36.83	71.2	66.02	80.07
Capital Expenditures, 5 Yr. CAGR %	-40.63	37.3	38.63	46.69	60.7
Levered Free Cash Flow, 5 Yr. CAGR %	-14.55	-10.45	80.55	-13.85	-11.94
Unlevered Free Cash Flow, 5 Yr. CAGR %	-11.57	25.98	104.6	-13.89	-8.19